ERYTHROMYCIN stearate, eq. 500mg base, tab.

STD DORAERYT5T-

Valid Article

Former Code(s): -X
6.2.2 - Watch group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01FA01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

ERYTHROMYCIN

Therapeutic Action

Macrolide antibacterial

Indications

Alternative to first-line antibiotic treatment of:

  • Louse-borne relapsing fever, leptospirosis
  • Acute otitis media, pharyngitis and sinusitis; diphtheria, pertussis, atypical pneumonia due to Mycoplasma pneumoniae or Chlamydophila pneumoniae
  • Furuncle, leg ulcer
  • Cervicitis and urethritis due to Chlamydia trachomatis (in combination with a treatment for gonorrhoea), donovanosis, chancroid, lymphogranuloma venereum, syphilis
  • Trachoma

Neonatal conjonctivitis due to Chlamydia trachomatis

Completion treatment following parenteral therapy with erythromycin

Instructions for use

The oral suspension is intended for paediatric use. To be reconstituted with filtered water.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • Reconstituted suspension: keep refrigerated between 2ºC and 8°C for up to 14 days.